Kang Lan
SEC CIK 1863043 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVTR | Avantor, Inc. | Dir | 52.3K | $62.9K | — | 7 | 2021-05-14 | 2025-05-08 |
Most active insiders at AVTR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MEHRA SANJEEV K | Dir | $4.88M | — |
| 2 | SUMME GREGORY L | Dir | $2.06M | — |
| 3 | Ligner Emmanuel | Pres, CEO, Dir | $993.1K | — |
| 4 | LUCIER GREGORY T | Dir | $541.2K | — |
| 5 | Dingemans Simon | Dir | $203.5K | — |
| 6 | Brellier Ludovic | EVP, Bioscience, Medtech | — | — |
| 7 | Blenn Mary | EVP, COO | — | — |
| 8 | Makin Louise | Dir | — | — |
| 9 | Gourdier Benoit | EVP, Bioscience, Medtech | — | — |
| 10 | Hankamer Brittany | EVP, Chief HR Off | — | — |
Kang Lan made no open-market trades at AVTR in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-12 | 2025-05-08 | AVTR | Avantor, Inc. | Kang Lan | Dir | A - Grant | $0.00 | +17.1K | 52.3K | +49% | $0 | |
| 2025-04-29 | 2025-04-28 | AVTR | Avantor, Inc. | Kang Lan | Dir | P - Purchase | $12.57 | +5,000 | 35.2K | +17% | +$62.9K | |
| 2024-05-13 | 2024-05-09 | AVTR | Avantor, Inc. | Kang Lan | Dir | A - Grant | $0.00 | +8,477 | 30.2K | +39% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Avantor, Inc. | Kang Lan | Dir | A - Grant | $0.00 | +9,808 | 21.7K | +82% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Avantor, Inc. | Kang Lan | Dir | A - Grant | $0.00 | +6,693 | 11.9K | +128% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Avantor, Inc. | Kang Lan | Dir | A - Grant | $0.00 | +1,215 | 5,237 | +30% | $0 | |
| 2021-12-17 | 2021-05-14 | AVTR | Avantor, Inc. | Kang Lan | Dir | A - Grant | $0.00 | +4,022 | 4,022 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations